ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response

Chen, Yan*; Sun, Zepang; Wan, Li; Chen, Hongzhuan; Xi, Tieju; Jiang, Yuming*广州医学院; 南方医科大学; y
Frontiers in Immunology2022-4-29DOI: 10.3389/fimmu.2022.890922
4被引10阅读
引用收藏
分享

摘要

BackgroundThe tumor microenvironment (TME) is crucial for tumor recurrence, prognosis, and therapeutic responses. We comprehensively investigated the TME characterization associated with relapse and survival outcomes of gastric cancer (GC) to predict chemotherapy and immunotherapy response. MethodsA total of 2,456 GC patients with complete gene-expression data and clinical annotations from twelve cohorts were included. The TME characteristics were evaluated using three proposed computational algorithms. We then developed a TME-classifier, a TME-cluster, and a TME-based risk score for the assessment of tumor recurrence and prognosis in patients with GC to predict chemotherapy and immunotherapy response. ResultsPatients with tumor recurrence presented with inactive immunogenicity, namely, high infiltration of tumor-associated stromal cells, low infiltration of tumor-associated immunoactivated lymphocytes, high stromal score, and low immune score. The TME-classifier of 4 subtypes with distinct clinicopathology, genomic, and molecular characteristics was significantly associated with tumor recurrence (P = 0.002), disease-free survival (DFS, P <0.001), and overall survival (OS, P <0.001) adjusted by confounding variables in 1,193 stage I-III GC patients who underwent potential radical surgery. The TME cluster and TME-based risk score can also predict DFS (P <0.001) and OS (P <0.001). More importantly, we found that patients in the TMEclassifier-A, TMEclassifier-C, and TMEclassifier-D groups benefited from adjuvant chemotherapy, and patients in the TMEclassifier-B group without chemotherapy benefit responded best to pembrolizumab treatment (PD-1 inhibitor), followed by patients in the TMEclassifier-A, while patients in the C and D groups of the TMEclassifier responded poorly to immunotherapy. ConclusionWe determined that TME characterization is significantly associated with tumor recurrence and prognosis. The TME-classifier we proposed can guide individualized chemotherapy and immunotherapy decision-making.

学科与关键词

关键词
tumor microenvironmentgastric cancerrecurrenceprognosischemotherapyimmunotherapyclassifier (classification tool)
相关
加载中…
  • Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
    Duan, Ran; Li, Xiaoqin; Zeng, Dongqiang; Chen, Xiaofeng; Shen, Bo; Zhu, Dongqin; Zhu, Liuqing; Yu, Yangyang; Wang, Deqiang*Frontiers in Immunology, 2021, 11: 609337.被引 12
  • An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy
    Chen, Tao*; Li, Xunjun; Mao, Qingyi; Wang, Yiyun; Li, Hanyi; Wang, Chen; Shen, Yuyang; Guo, Erjia; He, Qinglie; Tian, Jie; Zhu, Mansheng; Wu, Jing; Liang, Weiqi; Liu, Hao; Yu, Jiang; Li, Guoxin*Journal of Translational Medicine, 2022, 20(1): 100.被引 6
  • Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
    Zeng, Dongqiang; Wu, Jiani; Luo, Huiyan; Li, Yong; Xiao, Jian; Peng, Jianjun; Ye, Zilan; Zhou, Rui; Yu, Yunfang; Wang, Gaofeng; Huang, Na; Wu, Jianhua; Rong, Xiaoxiang; Sun, Li; Sun, Huiying; Qiu, Wenjun; Xue, Yichen; Bin, Jianping; Liao, Yulin; Li, Nailin; Shi, Min; Kim, Kyoung-Mee*; Liao, Wangjun*Journal for ImmunoTherapy of Cancer, 2021, 9(8): e002467.被引 83
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-04-29
卷期
第 13 卷
页码
890922
DOI
10.3389/fimmu.2022.890922
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • C

    Chen, Yan (通讯) (第一作者)

    2 · guangzhou med univ

  • S

    Sun, Zepang

    southern med univ

查看全部 6 位作者收起作者
  • W

    Wan, Li

    2 · guangzhou med univ

  • C

    Chen, Hongzhuan

    2 · guangzhou med univ

  • X

    Xi, Tieju

    2 · guangzhou med univ

  • J

    Jiang, Yuming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417